CD49d expression is included in a revised 4‐factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real‐world experience-Reference-Cited by-同舟云学术

CD49d expression is included in a revised 4‐factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real‐world experience

Published:2024-07 Issue:7 Volume:8 Page:
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:HemaSphere

Author:

Bomben Riccardo¹,Zucchetto Antonella¹,Laureana Roberta²,Chiarenza Annalisa³,Olivieri Jacopo⁴,Tissino Erika¹,Rossi Francesca M.¹,Vit Filippo¹,Bittolo Tamara¹,Papotti Robel¹,Pozzo Federico¹,Gaglio Annalisa¹,Degan Massimo¹,Polesel Jerry⁵,Marasca Roberto⁶⁷,Visentin Andrea⁸,Moia Riccardo⁹,Innocenti Idanna¹⁰,Vitale Candida¹¹,Murru Roberta¹²,Varettoni Marzia¹³,Tafuri Agostino¹⁴,Zaja Francesco¹⁵,Postorino Massimiliano²,Martino Enrica A.¹⁶,Condoluci Adalgisa¹⁷,Rossi Davide¹⁷,Cuneo Antonio¹⁸,Di Raimondo Francesco³,Sportoletti Paolo¹⁹,Del Giudice Ilaria²⁰,Foà Robin²⁰,Mauro Francesca R.²⁰,Coscia Marta¹¹,Laurenti Luca¹⁰,Gaidano Gianluca⁹,Trentin Livio⁸,Principe Maria I. Del²,Gentile Massimo¹⁶²¹,Gattei Valter¹

Affiliation:

1. Clinical and Experimental Onco‐Haematology Unit Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy

2. Division of Haematology University of Tor Vergata Rome Italy

3. Division of Hematology, Policlinico, Department of Surgery and Medical Specialties University of Catania Catania Italy

4. Clinica Ematologica, Centro Trapianti e Terapie Cellulari “Carlo Melzi” DISM Azienda Ospedaliera Universitaria S. Maria Misericordia Udine Italy

5. Unit of Cancer Epidemiology Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy

6. Hematology Unit, Department of Oncology and Hematology Azienda‐Ospedaliero Universitaria (AOU) of Modena, Policlinico Modena Italy

7. Department of Medical and Surgical Sciences University of Modena e Reggio Emilia Emilia‐Romagna Italy

8. Hematology unit, Department of Medicine University of Padova Padova Italy

9. Division of Hematology, Department of Translational Medicine Università del Piemonte Orientale Novara Italy

10. Fondazione Universitaria Policlinico A Gemelli di Roma Roma Italy

11. A.O.U. Città della Salute e della Scienza di Torino Torino Italy

12. Hematology and Stem Cell Transplantation Unit, Ospedale A. Businco, ARNAS G. Brotzu Cagliari Italy

13. Division of Hematology Fondazione IRCCS Policlinico San Matteo Pavia Italy

14. Department of Clinical and Molecular Medicine and Hematology, Sant'Andrea ‐ University Hospital ‐ Sapienza University of Rome Rome Italy

15. Department of Medical, Surgical and Health Sciences University of Trieste Trieste Italy

16. Hematology Unit Azienda Ospedaliera Annunziata Cosenza Italy

17. Oncology Institute of Southern Switzerland and Institute of Oncology Research Bellinzona Switzerland

18. Hematology Section, Department of Medical Sciences University of Ferrara Ferrara Italy

19. Centro di Ricerca Emato‐Oncologica (CREO), Dipartimento di Medicina e Chirurgia Università di Perugia Perugia Italy

20. Hematology, Department of Translational and Precision Medicine ‘Sapienza’ University Rome Italy

21. Department of Pharmacy, Health and Nutritional Science University of Calabria Rende Italy

Funder

Associazione Italiana Contro le Leucemie-Linfomi e Mieloma

Ministero della Salute

Associazione Italiana per la Ricerca sul Cancro

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hem3.128

Reference15 articles.

1. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL

2. Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures

3. CD38/CD31, the CCL3 and CCL4 Chemokines, and CD49d/Vascular Cell Adhesion Molecule-1 Are Interchained by Sequential Events Sustaining Chronic Lymphocytic Leukemia Cell Survival

4. CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression

5. Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia